Pathway Genomics Receives Investment from IBM Watson Group

pathway genomicsPathway Genomics Corporation, a San Diego, California-based clinical laboratory that offers genetic testing services globally, received an investment from IBM Watson Group.

The company has raised more than $80m since inception.

Founded in 2008, Pathway Genomics is a CLIA and CAP accredited clinical laboratory that provides physicians and their patients with actionable and accurate genetic information to improve or maintain health and wellness. Its testing services cover a variety of conditions including cancer risk, cardiac health, inherited diseases, nutrition and exercise response, as well as drug response for specific medications including those used in pain management and mental health.

By leveraging the natural language processing and cognitive capabilities of Watson, the company is building Pathway Panorama, a mobile app that will allow consumers to ask the Pathway Panorama app questions to gain insights and options powered by the cognitive intellect of Watson, based on their own wellness-related genes, wearable data, and other related wellness information, like emotional, physical and social well being. As an example, a user will be able to ask the app questions based on their DNA, like “How much exercise should I do today?” to “How much coffee can I drink on Monday?” The cognitive app answers and provides options based on the millions of healthcare-related evidence-based data, ingested by Watson and on the individual’s biomarker, vital signs (wearables), DNA, electronic health records, and other information.



Join the discussion